Apigenin increases osteoblastic differentiation and inhibits tumor necrosis factor-α-induced production of interleukin-6 and nitric oxide in osteoblastic MC3T3-E1 cells

Pharmazie

Volumn 62, Issue 3, 2007, Pages 216-220

  Choi, Eun Mi ^a  

^a Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; APIGENIN; CYCLOHEXIMIDE; INTERLEUKIN 6; NITRIC OXIDE; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METABOLISM; BONE REMODELING; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; ESTROGEN ACTIVITY; IMMUNOASSAY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOBLASTOMA; OSTEOLYSIS; OSTEOPOROSIS; RECEPTOR BINDING;

3T3 CELLS; ALKALINE PHOSPHATASE; ANIMALS; APIGENIN; CELL DIFFERENTIATION; CELL SURVIVAL; COLLAGEN; IMMUNOASSAY; INDICATORS AND REAGENTS; INTERLEUKIN-6; MICE; NITRIC OXIDE; OSTEOBLASTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33947417220     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.3.6629     Document Type: Article

References (33)

1. Arts J, Kuiper GGJM, Jenssen JMMF, Gustafsson J-A, Lowik CWGM, Pols HAP, Van Leeuwen JPTM (1997) Differential expression of estrogen receptors a and b mRNA during differentiation of human osteoblsat SV-HFO cells. Endocrinology 138: 5067-5070.
2. Chen XW, Garner SC, Quarles LD, Anderson JJB (2003) Effects of genistein on expression cell of bone markers during MC3T3-E1 osteoblastic differentiation. J Nutr Biochem 14: 342-349.
3. Fernandez-de-Simon B, Perez-Ilzarbe J, Hernandez T, Gomez-Cordoves C, Estrella I (1992) Importance of phenolic compounds for the characterization of fruit juices. J Agric Food Chem 40: 1531-1535.
4. Franchimont N, Rydziel S, Canalis E (1997) Interleukin 6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells. J Clin Invest 100: 1797-1803.
5. Galien R, Evans HF, Garcia T (1996) Involvement of CCAAT/enhancer-binding protein and nuclear factor-kappa B binding sites in interleukin-6 promoter inhibition by estrogens. Mol Endocrinol 10: 713-722.
6. Girasole G, Jilka RL, Passeri G, Boswell S, Williams DC, Manolagas S (1992) 17β-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89: 883-891.
7. Haraoui B, Pelletier JP, Cloutier JM, Faure MP, Martel-Pelletier J (1991) Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. In vivo effects of antirheumatic drugs. Arthritis Rheum 34: 153-163.
8. Hukkanen M, Hughes FJ, Buttery LD, Gross SS, Evans TJ, Seddon S, Riveros-Moreno V, Macintyre I, Polak JM (1995) Cytokine stimulated expression of inducible nitric oxide synthase by mouse, rat and human osteoblast-like cells and its functional role in osteoblast metabolic activity. Endocrinology 136: 5445-5453.
9. Ikegami A, Inoue S, Hosoi T, Mizuno Y, Nakamura T, Ouchi Y, Orimo H (1993) Immunohistochemical detection and northern blot analysis of estrogen-receptor in osteoblastic cells. J Bone Miner Res 8: 1103-1109.
10. Jarry H, Spengler B, Porzel A, Schmidt J, Wuttke W, Christoffel V (2003) Evidence for estrogen receptor beta-selective activity of Vitex agnus-castus and isolated flavones. Planta Med 69: 945-947.
11. Kanno S, Anuradha CD, Hirano S (2001) Localization of zinc after in vitro mineralization in osteoblastic cells. Biol Trace Elem Res 83: 39-47.
12. Kassem M, Harris S, Spelsberg TC, Riggs BL (1996) Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high level of estrogen receptors. J Bone Miner Res 11: 193-199.
13. Kimble RB, Matayoshi AB, Vannice JL, Kung VT, Williams C, Pacifici R (1995) Simultaneous block of IL-1 and TNF is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136: 3054-3061.
14. Kleinerman ES, Lachman LB, Knowles RD, Snyderman R, Cianciolo GJ (1987) A synthetic peptide homologous to the envelope proteins of retroviruses inhibits monocyte-mediated killing by inactivating interleukin 1. J Immunol 139: 2329-2337.
15. Kodama HA, Suda Y, Kasai H, Yamamoto S (1981) Establishment of a clonal osteogenic cell line from newborn mouse calvaria. Jpn. J Oral Biol 23: 899-901.
16. Kuiper GGJM, Carlsson B, Gardien K, Enmark E, Haggblad J, Nilsson S, Gustafsson J-A (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138: 863-870.
17. Mancini L, Moradi-Bidhendi N, Becherini L, Martineti V, Macintyre I (2000) The biphasic effects of nitric oxide in primary rat osteoblasts are cGMP dependent. Biochem Biophys Res Commum 274: 477-481.
18. Mayer B, Hermens B (1997) Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem Sci 22: 477-481.
19. Pacifici R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D, McCracken R, Avioli LV (1991) Effect of surgical menopause and estrogen replacement in cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 88: 5134-5138.
20. Pelletier JP, McCollum R, Cloutier JM, Martel-Pelletier J (1995) Synthesis of metalloproteases and interleukin 6 (IL-6) in human osteoarthritic synovial membrane is an IL-1-mediated process. J Rheumatol Suppl 43: 109-114.
21. Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ (1992) Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Min Res 7: 683-692.
22. Raize LG, Martin TJ (1983) Prostaglandins in bone and mineral metabolism. In Bone & Mineral Research, vol 2, Peck WA (ed.) Elsevier/North Holland: Amsterdam, p. 286-310.
23. Ralston SH, Todd D, Helfrich M, Benjamin N, Grabowski PS (1994) Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 135: 330-336.
24. Raso GM, Meli R, Di Carlo G, Pacilio M, Di Carlo R (2001) inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774a.1, Life Sci 68: 921-931.
25. Riggs BL, Melton III LJ (1992) The prevention and treatment of osteoporosis. N Engl J Med 327: 620-627.
26. Roodman GD (1996) Advances in bone biology: the osteoblast. Endocrinol Rev 17 : 308-332.
27. Santti R, Makela S, Strauss L, Korkman J, Kostian ML (1998) Phytoestrogens: Potential endocrine disruptors in males. Toxicol Ind Health 14: 223-237.
28. Shukla S, Gupta S (2004) Molecular mechanisms for apigenin-induced cell-cycle arrest and apoptosis of hormone refractory human prostate carcinoma DU145 cells. Mol Carcinogen 39: 114-126.
29. Stein GS, Lian JB, Owen TA (1990) Relationship of cell growth to the regulation of tissue-specific gene expression during progressive osteoblast differentiation. FASEB J 4: 111-123.
30. Strom SS, Yamamura Y, Duphorne CM, Spitz MR, Babaian RJ, Pillow PC, Hursting SD (1999) Phytoestrogen intake and prostate cancer: A case-control study using a new database. Nutrition Cancer 33: 20-25.
31. Sudo H, Kodama HA, Amagai Y, Yamamoto S, Kasai S (1983) In vitro differentiation and calcification in a new clonal osteogenic cell line derived from new-born mouse calvaria. J Cell Biol 96: 191-198.
32. Weinreb M, Rodan GA, Thompson DD (1989) Osteopenia in the immobilized rat hind limb is associated with increased bone resorption and decreased bone formation. Bone 10: 187-194.
33. Yamaguchi M, Gao YH (1997) Anabolic effect of genistein on bone metabolism in the femoral-metaphyseal tissues of elderly rats is inhibited by the anti-estrogen tamoxifen. Res Exp Med 197: 101-107.